Discover 1,546 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,546
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Aurora CO, Minneapolis MN, Memphis TN, Palo Alto CA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT04901702
Phase 1, Phase 2, Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
for
Primary Immunoglobulin A Nephropathy (IgAN)
Location: Aurora CO, Salt Lake City UT, Madera CA, Gainesville FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 18
Code: NCT06994845
Phase 3, Recruiting
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Aurora CO, Salt Lake City UT, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase 3, Recruiting
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Location: Aurora CO, San Diego CA, Calgary, Chicago IL,
Sponsor: Boston Children's Hospital
Sex: All
Age: 0+
Code: NCT04507997
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Aurora CO, Salt Lake City UT, Little Rock AR, Irvine CA,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Phase 4, Recruiting
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
for
Pitt Hopkins Syndrome
Location: Aurora CO, Oakland CA, Chicago IL
Sponsor: Mahzi Therapeutics
Sex: All
Age: 2 - 25
Code: NCT07135050
Phase 1, Phase 2, Recruiting
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
for
Diabetes Mellitus Type 2, Childhood-Onset
Location: Aurora CO, Shiprock NM, Oklahoma City OK, Phoenix AZ,
Sponsor: George Washington University
Sex: All
Age: 8 - 15
Code: NCT06525259
Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Aurora CO, Omaha NE, Phoenix AZ, Minneapolis MN,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase 3, Recruiting
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Aurora CO, St Louis MO, Harlingen TX, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 2 - 17
Code: NCT07158242
Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Aurora CO, Chandler AZ, Henderson NV, Waukee IA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06588478
Phase 2, Recruiting
International CDKL5 Clinical Research Network
for
CDKL5, CDKL5 Deficiency Disorder, CDD
Location: Aurora CO, Saint Louis MO, Los Angeles CA, Houston TX,
Sponsor: University of Colorado, Denver
Sex: All
Age: 0 - 70+
Code: NCT05558371
Recruiting
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
Location: Aurora CO, San Diego CA, Los Angeles CA, Houston TX,
Sponsor: Starlight Cardiovascular Inc
Sex: All
Age: 0
Code: NCT07114718
Recruiting
Venetoclax Basket Trial for High Risk Hematologic Malignancies
for
Myelodysplastic Syndromes, de Novo,
Location: Aurora CO, Chicago IL, San Francisco CA, Atlanta GA,
Sponsor: Andrew E. Place, MD
Sex: All
Age: 1 - 40
Code: NCT05292664
Phase 1, Recruiting
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia